The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic PLC's $458 million acquisition of Twelve, Inc.
Medtronic will pay $408 million up-front for privately held Twelve, plus another $50 million when a transcatheter mitral valve based...